Sofinnova Investments as of June 30, 2019
Portfolio Holdings for Sofinnova Investments
Sofinnova Investments holds 69 positions in its portfolio as reported in the June 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ascendis Pharma A S (ASND) | 11.6 | $127M | 1.1M | 115.15 | |
| Amarin Corporation | 9.3 | $101M | 5.2M | 19.39 | |
| Natera (NTRA) | 7.9 | $86M | 3.1M | 27.58 | |
| Principia Biopharma | 6.2 | $68M | 2.0M | 33.19 | |
| Obseva Sa | 4.9 | $54M | 4.7M | 11.31 | |
| Spark Therapeutics | 4.5 | $49M | 481k | 102.38 | |
| Y Mabs Therapeutics | 4.4 | $48M | 2.1M | 22.87 | |
| Coherus Biosciences (CHRS) | 4.2 | $46M | 2.1M | 22.10 | |
| Nextcure | 3.5 | $38M | 2.5M | 14.98 | |
| Audentes Therapeutics | 3.2 | $35M | 934k | 37.86 | |
| Karuna Therapeutics Ord | 3.2 | $35M | 1.7M | 20.02 | |
| Merus N V (MRUS) | 2.6 | $29M | 2.0M | 14.65 | |
| Nucana Biomed ordinary shares | 2.3 | $25M | 2.4M | 10.38 | |
| Nucana Plc american depositary shares | 2.2 | $24M | 2.3M | 10.38 | |
| Ptc Therapeutics I (PTCT) | 1.5 | $17M | 369k | 45.00 | |
| Novo Nordisk A/S (NVO) | 1.5 | $17M | 324k | 51.04 | |
| Allergan | 1.3 | $14M | 84k | 167.42 | |
| Neurocrine Biosciences (NBIX) | 1.2 | $13M | 156k | 84.42 | |
| Kiniksa Pharmaceuticals | 1.1 | $13M | 923k | 13.54 | |
| Chiasma | 1.1 | $12M | 1.6M | 7.47 | |
| Halozyme Therapeutics (HALO) | 1.1 | $12M | 690k | 17.18 | |
| Iterum Therapeutics | 1.1 | $12M | 1.7M | 6.88 | |
| Heron Therapeutics (HRTX) | 1.1 | $12M | 617k | 18.59 | |
| Tg Therapeutics (TGTX) | 1.0 | $11M | 1.3M | 8.65 | |
| Reata Pharmaceuticals Inc Cl A | 1.0 | $11M | 116k | 94.36 | |
| Acceleron Pharma | 0.9 | $9.9M | 241k | 41.08 | |
| Macrogenics (MGNX) | 0.9 | $9.3M | 550k | 16.97 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 0.8 | $9.2M | 50k | 183.40 | |
| Amgen Inc option | 0.8 | $9.2M | 50k | 184.28 | |
| Morphosys (MPSYF) | 0.8 | $9.2M | 96k | 96.01 | |
| Allergan Plc call | 0.8 | $8.4M | 50k | 167.44 | |
| Bristol Myers Squibb (BMY) | 0.7 | $7.9M | 174k | 45.34 | |
| Entasis Therapeutics Holdings Ord | 0.7 | $7.6M | 1.2M | 6.45 | |
| BioMarin Pharmaceutical (BMRN) | 0.7 | $7.3M | 85k | 85.65 | |
| Amicus Therapeutics (FOLD) | 0.7 | $7.3M | 583k | 12.48 | |
| Dermira | 0.6 | $6.3M | 660k | 9.56 | |
| Incyte Corporation (INCY) | 0.5 | $5.9M | 70k | 84.97 | |
| Synlogic | 0.5 | $5.2M | 575k | 9.10 | |
| Orchard Therapeutics Plc ads | 0.5 | $5.1M | 366k | 13.99 | |
| Bristol-myers Squibb | 0.4 | $4.5M | 100k | 45.35 | |
| Kadmon Hldgs | 0.4 | $4.5M | 2.2M | 2.06 | |
| ACADIA Pharmaceuticals (ACAD) | 0.4 | $4.2M | 156k | 26.73 | |
| Akebia Therapeutics (AKBA) | 0.4 | $4.1M | 848k | 4.84 | |
| Aclaris Therapeutics (ACRS) | 0.4 | $4.2M | 1.9M | 2.19 | |
| Zymeworks | 0.4 | $4.1M | 188k | 21.99 | |
| Uniqure Nv (QURE) | 0.4 | $3.9M | 50k | 78.17 | |
| Otonomy | 0.3 | $3.7M | 1.3M | 2.75 | |
| ArQule | 0.3 | $3.1M | 282k | 11.01 | |
| Foamix Pharmaceuticals | 0.2 | $2.7M | 1.1M | 2.38 | |
| Xbiotech (XBIT) | 0.2 | $2.5M | 332k | 7.58 | |
| Zogenix Inc call | 0.2 | $2.4M | 50k | 47.79 | |
| Intra Cellular Therapies | 0.2 | $2.3M | 175k | 12.98 | |
| Syndax Pharmaceuticals (SNDX) | 0.2 | $2.3M | 243k | 9.32 | |
| Deciphera Pharmaceuticals In put | 0.2 | $2.3M | 100k | 22.56 | |
| Adverum Biotechnologies | 0.2 | $2.2M | 187k | 11.89 | |
| Alnylam Pharmaceuticals (ALNY) | 0.2 | $2.0M | 28k | 72.54 | |
| Abbvie (ABBV) | 0.2 | $2.1M | 29k | 72.74 | |
| Calithera Biosciences | 0.2 | $2.1M | 530k | 3.90 | |
| Osmotica Pharmaceuticals (RVLPQ) | 0.2 | $2.0M | 525k | 3.80 | |
| Clovis Oncology | 0.2 | $1.9M | 125k | 14.88 | |
| Kala Pharmaceuticals | 0.2 | $1.9M | 297k | 6.38 | |
| BioCryst Pharmaceuticals (BCRX) | 0.1 | $1.6M | 426k | 3.79 | |
| Intra Cellular Therapies (ITCI) | 0.1 | $1.6M | 126k | 12.98 | |
| Acorda Therapeutics | 0.1 | $1.5M | 194k | 7.66 | |
| Apellis Pharmaceuticals (APLS) | 0.1 | $1.3M | 50k | 25.33 | |
| Forty Seven | 0.1 | $1.3M | 119k | 10.59 | |
| Applied Therapeutics | 0.1 | $1.2M | 142k | 8.24 | |
| Autolus Therapeutics Plc spon ads (AUTL) | 0.1 | $1.1M | 66k | 16.09 | |
| Pds Biotechnology Ord (PDSB) | 0.1 | $854k | 143k | 5.99 |